Global Financial Private Client’s GSK GSK Stock Holding History

Global Financial Private Client’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-1,279	Closed	-$52.3K	–	1673
2024 Q3	$52.3K	Buy	1,279 +259	+25%	+$10.6K	0.02%	317
2024 Q2	$39.3K	Hold	1,020	–	–	0.02%	324
2024 Q1	$43.3K	Hold	1,020	–	–	0.02%	317
2023 Q4	$37.8K	Hold	1,020	–	–	0.02%	321
2023 Q3	$36.8K	Hold	1,020	–	–	0.02%	312
2023 Q2	$36K	Hold	1,020	–	–	0.02%	319
2023 Q1	$36.7K	Hold	1,020	–	–	0.02%	311
2022 Q4	$35.8K	Hold	1,020	–	–	0.02%	303
2022 Q3	$30.9K	Hold	1,020	–	–	0.02%	312
2022 Q2	$55.8K	Hold	1,020	–	–	0.03%	255
2022 Q1	$56K	Hold	1,020	–	–	0.03%	255
2021 Q4	$56.2K	Hold	1,020	–	–	0.03%	260
2021 Q3	$48.6K	Hold	1,020	–	–	0.03%	248
2021 Q2	$51.2K	Hold	1,020	–	–	0.03%	247
2021 Q1	$45.7K	Hold	1,020	–	–	0.03%	217
2020 Q4	$46.9K	Hold	1,020	–	–	0.04%	200
2020 Q3	$47.4K	Sell	1,020 -704	-41%	-$35.3K	0.04%	197
2020 Q2	$88.1K	Sell	1,724 -339	-16%	-$17.4K	0.08%	157
2020 Q1	$96K	Hold	2,063	–	–	0.1%	144
2019 Q4	$121K	Buy	+2,063	New	+$115K	0.1%	149

Other funds holding GSK

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

JEST

JTC Employer Solutions Trustee St Helier, Jersey $1.2B AUM 37.55% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Global Financial Private Client's GSK Position: Q4 2024 in Review

Global Financial Private Client sold out of GSK (GSK) in Q4 2024, closing a stake of 1,279 shares — an estimated $52.3K sold.

Global Financial Private Client first reported a position in GSK in Q4 2019 and held it in 20 quarters. The position peaked at $121K in Q4 2019. 848 funds tracked by Wall St. Rank hold GSK as of Q4 2024.

Global Financial Private Client reported no remaining GSK position as of Q4 2024 after selling out during the quarter.
Global Financial Private Client sold 1,279 GSK shares in Q4 2024, an estimated $52.3K.
Global Financial Private Client first reported a position in GSK in Q4 2019 and held it in 20 quarters.
Global Financial Private Client's GSK position peaked at $121K in Q4 2019.
848 funds tracked by Wall St. Rank held GSK as of Q4 2024.

Based on Global Financial Private Client's 13F filing for Q4 2024, filed 14 Jan 2025.